Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.3 appears in the page footer, replacing v3.4.2. No changes to the study record content or navigation are observed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1; no core trial content, outcomes, or critical information appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a Show glossary option and updated the footer text to No FEAR Act Data; the revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe update represents a minor version bump (Revision: v3.3.4) with no visible impact on study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page shows the revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.